Expression of bactericidal/permeability-increasing protein requires C/EBPε

International Journal of Hematology

Volumn 85, Issue 4, 2007, Pages 304-311

  Tanaka, Miyuki ^a   Gombart, Adrian F ^b   Koeffler, H Phillip ^b   Shiohara, Masaaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

Author keywords

Inflammation; Innate immunity; Neutrophil; Primary granule

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN EPSILON; MESSENGER RNA; RETINOIC ACID; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; BONE MARROW CELL; CELL GRANULE; CELL STRAIN U937; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOTOXICITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MUTATION; GENETIC TRANSFECTION; GRAM NEGATIVE BACTERIUM; HOMOZYGOTE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUTROPHIL; NONHUMAN; PROMOTER REGION; UMBILICAL CORD BLOOD; UPREGULATION; WILD TYPE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CCAAT-ENHANCER-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUTAGENESIS, INSERTIONAL; MUTATION; NEUTROPHILS; PROTEIN BINDING; PROTEINS; RESPONSE ELEMENTS; RNA, MESSENGER; SECRETORY VESICLES; U937 CELLS;

EID: 34547515063     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05162     Document Type: Article

References (38)

1. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89:3503-3521.
2. Gullberg U, Andersson E, Garwicz D, Lindmark A, Olsson I. Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development. Eur J Haematol. 1997;58:137-153.
3. Weiss J, Olsson I. Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood. 1987;69:652-659.
4. Calafat J, Janssen H, Tool A, et al. The bactericidal/permeability- increasing protein (BPI) is present in specific granules of human eosinophils. Blood. 1998;91:4770-4775.
5. Dentener MA, Francot GJ, Buurman WA. Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes. J Infect Dis. 1996;173:252-255.
6. Canny G, Levy O, Furuta GT, et al. Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci USA. 2002;99:3902-3907.
7. 2-independent bactericidal system. J Clin Invest. 1982;69:959-970.
8. Weinrauch Y, Foreman A, Shu C, et al. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest. 1995;95:1916-1924.
9. Gazzano-Santoro H, Parent JB, Grinna L, et al. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun. 1992;60:4754-4761.
10. Weiss J, Elsbach O, Shu C, et al. Human bactericidal/permeability- increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest. 1992;90:1122-1130.
11. Mannion BA, Weiss J, Elsbach P. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. J Clin Invest. 1990;86:631-641.
12. Wiese A, Brandenburg K, Lindner B, et al. Mechanism of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates. Biochemistry. 1997;36:10301-10310.
13. Iovine NM, Elsbach P, Weiss J. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc Natl Acad Sci U S A. 1997;94:10973-10978.
14. Martin TR, Mathison JC, Tobias PS, et al. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. J Clin Invest. 1992;90:2209-2219.
15. Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol. 1992;148:532-537.
16. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol. 1998;64:14-18.
17. Antonson P, Stellan B, Yamanaka R, Xanthopoulos KG. A novel human CCAAT/enhancer binding protein gene, C/EBPε, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor α/δ locus. Genomics. 1996;35:30-38.
18. Chumakov AM, Grillier I, Chumakova E, Chih D, Slater J, Koeffler HP. Cloning of the novel human myeloid-cell-specific C/EBPε transcription factor. Mol Cell Biol. 1997;17:1375-1386.
19. Verbeek W, Gombart AF, Chumakov AM, Müller C, Friedman AD, Koeffler HP. C/EBPε directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. Blood. 1999;93:3327-3337.
20. Verbeek W, Lekstrom-Himes J, Park DJ, et al. Myeloid transcription factor C/EBPε is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood. 1999;94:3141-3150.
21. Komiyama A, Morosawa H, Nakahata T, Miyagawa Y, Akabane T. Abnormal neutrophil maturation in a neutrophil defect with morphologic abnormality and impaired function. J Pediatr. 1979;94:19-25.
22. Lekstom-Himes JA, Dorman SE, Kopar P, Holland SM, Gallin JI. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein ε. J Exp Med. 1999;189:1847-1852.
23. Gombart A, Shiohara M, Kwok SH, Agematsu K, Komiyama A, Koeffler HP. Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-ε. Blood. 2001;97:2561-2567.
24. Shiohara M, Gombart AF, Sekiguchi Y, et al. Phenotypic and functional alterations of peripheral blood monocytes in neutrophil-specific granule deficiency. J Leukoc Biol. 2004;75:190-197.
25. Ambruso DR, Sasada M, Nishiyama H, Kubo A, Komiyama A, Allen RH. Defective bactericidal activity and absence of specific granules in neutrophils from a patient with recurrent bacterial infections. J Clin Immunol. 1984;4:23-30.
26. Tamura A, Agematsu K, Mori T, et al. A marked decrease in defensin mRNA in the only case of congenital neutrophil-specific granule deficiency reported in Japan. Int J Hematol. 1994;59:137-142.
27. Shiohara M, Taniguchi S, Masumoto J, et al. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun. 2002;293:1314-1318.
28. Park DJ, Chumakov AM, Vuong PT, et al. CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest. 1999;103:1399-1408.
29. Levy O, Martin S, Eichenwald E, et al. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability- increasing protein. Pediatrics. 1999;104:1327-1333.
30. Lennartsson A, Pieters K, Ullmark T, Vidovic K, Gullberg U. AML-1, PU.1, and Sp3 regulate expression of human bactericidal/permeability-increasing protein. Biochem Biophys Res Commun. 2003;311:853-863.
31. Gombart AF, Kwok SH, Anderson KL, et al. Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBPε and PU.1. Blood. 2003;101:3265-3273.
32. Rosenberg HF, Gallin JI. Neutrophil-specific granule deficiency includes eosinophils. Blood. 1993;82:268-273.
33. Lennartsson A, Pieters K, Vidovic K, Gullberg U. A murine antibacterial orthologue to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow. J Leukoc Biol. 2005;77:369-377.
34. Morosetti R, Park DJ, Chumakov AM, et al. A novel, myeloid transcription factor, C/EBPε, is upregulated during granulocytic, but not monocytic differentiation. Blood. 1997;90:2591-2600.
35. Faurschou M, Borregaad N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5:1317-1327.
36. Heumann D, Gallay P, Barras C, et al. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J Immunol. 1992;148:3505-3512.
37. Martin TR, Mathison JC, Tobias PS, et al. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide: implications for cytokine production in normal and injured lungs. J Clin Invest. 1992;90:2209-2219.
38. Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurman WA. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. J Immunol. 1993;151:4258-4265.